Related Experiment Video
Updated: Jun 27, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder
Sarah Kayser1, Bettina Bewernick, Nikolai Axmacher
1Department of Psychiatry and Psychotherapy, University Hospital, Bonn, Germany.
Abstract:
Electroconvulsive therapy (ECT) is a highly efficacious treatment for severe depression. However, a disadvantage of ECT is the risk of cognitive side effects. Magnetic seizure therapy (MST) is a novel treatment modality, by which therapeutic seizures are induced using rapidly alternating strong magnetic fields. In this case study, we report on successful MST treatment of an episode of otherwise treatment-resistant depression in a patient with bipolar I disorder. Compared with published ECT results, MST seizures in this case report were of shorter duration, lower ictal electroencephalogram amplitude, and less pronounced postictal suppression. Furthermore, the patient did not experience subjective side effects and particularly recovered time to full orientation more quickly with MST than what has been previously described for ECT. Taken together, these results suggest that MST, compared with ECT, might have antidepressant effects and may have fewer clinical side effects.
Related Concept Videos
Electroconvulsive Therapy
Mania and Antimanic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
